Medical experts from Wuhan, the city hardest hit by the novel coronavirus disease (COVID-19) in central China's Hubei Province, have recently shared treatment experience with peers from 24 countries via a video conference.
A total of 15,000 people watched the global broadcast live.
As one of the major battlefields in combating COVID-19, hospitals in Wuhan have accumulated rich clinical treatment experience which medics there would like to share with global counterparts, said Hu Yu, president of the Unio Hospital in Wuhan.
China has been actively sharing scientific knowledge and research results about COVID-19 with the world. Chinese scientists and health experts have carried out timely technical exchanges with the international community to help them develop testing kits and adopt responsive measures.
The latest diagnosis and treatment plan, prevention and control plan and other technical documents have been compiled, translated and promptly shared with over 180 countries and more than 10 international and regional organizations, said Zeng Yixin, deputy director of the National Health Commission.
The information and knowledge sharing started from a very early stage when the novel coronavirus was not yet identified.
At the early stage, Chinese researchers were racing against time to formulate a detailed profile of the virus. On Jan. 12, it submitted to the WHO the genome sequence of the virus, which was published by the Global Initiative on Sharing All Influenza Data.
Chinese researchers have also dug into the source of the virus, its transmission routes and the patients' clinical symptoms to offer references for the COVID-19 prevention, control and treatment.
The Chinese government encouraged researchers and frontline doctors to publish their findings in international journals to facilitate information sharing and communication with foreign counterparts.
By March 26, Chinese researchers had published 54 research papers on prestigious international journals, and a platform for COVID-19 research sharing went online on Chinese Medical Journal Network with more than 700 research papers recording 2.3 million views.
China has built two platforms to share its scientific developments. One of the platforms, a database of COVID-19, has recorded more than 4 million downloads by users from 152 countries and regions as of the end of March.
China has kept upgrading diagnosis and treatment plans and Chinese researchers have kept searching for more effective drugs and exploring new treatment methods.
China is also pushing forward the utilization of some advanced technologies such as stem cell and artificial liver and blood purification in the treatment of severe cases.
Vice Minister of Science and Technology Xu Nanping said China would share all the clinical trial results of COVID-19 drugs with the world and Chinese researchers were looking forward to launching or participating in more international multi-center clinical trials to identify and fast track promising potential treatments for COVID-19.
